Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Malignant Melanoma

Free Subscription 09.09.2019 1 Am J Dermatopathol 1 Am J Pathol 4 Ann Surg Oncol 1 Biochem Biophys Res Commun 2 Br J Dermatol 1 Cancer Lett 1 Cancer Res 2 Clin Cancer Res 1 J Am Acad Dermatol 1 J Invest Dermatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Dermatopathol

1. WEYERS W
   "Personalized Excision" of Malignant Melanoma-Need for a Paradigm Shift in the Beginning Era of Personalized Medicine.
   Am J Dermatopathol. 2019 Aug 29. doi: 10.1097/DAD.0000000000001450.
   PubMed     Text format     Abstract available
   
   

   
   Am J Pathol

2. ZHOU Y, Song KY, Giubellino A
   The role of MET in melanoma and melanocytic lesions.
   Am J Pathol. 2019 Aug 30. pii: S0002-9440(19)30703.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg Oncol

3. EL SHAROUNI MA, Witkamp A, Sigurdsson V, van Diest PJ, et al
   ASO Author Reflections: Sentinel Lymph Node Biopsy Trend in Melanoma: The More the Merrier.
   Ann Surg Oncol. 2019 Sep 5. pii: 10.1245/s10434-019-07660.
   PubMed     Text format    
   
   
4. SONG Y, Azari FS, Metzger DA, Fraker DL, et al
   Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study.
   Ann Surg Oncol. 2019 Sep 4. pii: 10.1245/s10434-019-07783.
   PubMed     Text format     Abstract available
   
   
5. FRANCKEN AB, Hoekstra-Weebers JEHM, Deckers E, Hoekstra HJ, et al
   ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified.
   Ann Surg Oncol. 2019 Sep 3. pii: 10.1245/s10434-019-07611.
   PubMed     Text format    
   
   
6. BEASLEY GM, Zager JS, Thompson JF
   The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma.
   Ann Surg Oncol. 2019 Aug 30. pii: 10.1245/s10434-019-07760.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

7. PARK J, Jeong D, Jang B, Oh ES, et al
   The melanocortin-1 receptor reversely regulates the melanin synthesis and migration of melanoma cells via dimerization-induced conformational changes.
   Biochem Biophys Res Commun. 2019 Aug 28. pii: S0006-291X(19)31652.
   PubMed     Text format     Abstract available
   
   

   
   Br J Dermatol

8. STILLER HT, Mikiver R, Uppugunduri S, Lindholm C, et al
   Health Related Quality of Life in Melanoma Patients - characterization of a Swedish cohort.
   Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18486.
   PubMed     Text format     Abstract available
   
   
9. BAILEY EE, Mayer JE, Geller AC, Johnson TM, et al
   Role of the partner/spouse in melanoma discovery and related health behaviors and practices.
   Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18478.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Lett

10. VOSHTANI R, Song M, Wang H, Li X, et al
    Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.
    Cancer Lett. 2019;465:24-35.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

11. NEVALA WK, Buhrow SA, Knauer DJ, Reid JM, et al
    Correction: Antibody-Targeted Chemotherapy for the Treatment of Melanoma.
    Cancer Res. 2019;79:4551.
    PubMed     Text format    
    
    

    
    Clin Cancer Res

12. EDWARDS J, Batten M, Ferguson A, Palendira U, et al
    Novel Immune Targets in Melanoma-Response.
    Clin Cancer Res. 2019;25:5424-5425.
    PubMed     Text format    
    
    
13. NOCENTINI G, Cari L, Riccardi C
    Novel Immune Targets in Melanoma-Letter.
    Clin Cancer Res. 2019;25:5422-5423.
    PubMed     Text format    
    
    

    
    J Am Acad Dermatol

14. HANSON J, Demer A, Liszewski W, Foman N, et al
    Improved Overall Survival of Melanoma of the Head and Neck Treated with Mohs Micrographic Surgery versus Wide Local Excision.
    J Am Acad Dermatol. 2019 Aug 29. pii: S0190-9622(19)32665.
    PubMed     Text format     Abstract available
    
    

    
    J Invest Dermatol

15. ZHU G, Xu P, Guo S, Yi X, et al
    Metastatic melanoma cells rely on Sestrin2 to acquire anoikis resistance via detoxifying intracellular ROS.
    J Invest Dermatol. 2019 Aug 30. pii: S0022-202X(19)33208.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

16. 
    Correction: Differential roles of gangliosides in malignant properties of melanomas.
    PLoS One. 2019;14:e0222220.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: